400 related articles for article (PubMed ID: 33218331)
21. Combined modalities of magnetic resonance imaging, endoscopy and computed tomography in the evaluation of tumor responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma.
Qiu B; Wang D; Yang H; Xie W; Liang Y; Cai P; Chen Z; Liu M; Fu J; Xie C; Liu H
Radiother Oncol; 2016 Nov; 121(2):239-245. PubMed ID: 27793445
[TBL] [Abstract][Full Text] [Related]
22. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
[TBL] [Abstract][Full Text] [Related]
23. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
[No Abstract] [Full Text] [Related]
24. Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma.
Wang BY; Wu SC; Chen HC; Hung WH; Lin CH; Huang CL; Chen HS
Br J Surg; 2019 Feb; 106(3):255-262. PubMed ID: 30395362
[TBL] [Abstract][Full Text] [Related]
25. High expression level of CD44v8-10 in cancer stem-like cells is associated with poor prognosis in esophageal squamous cell carcinoma patients treated with chemoradiotherapy.
Kagami T; Yamade M; Suzuki T; Uotani T; Tani S; Hamaya Y; Iwaizumi M; Osawa S; Sugimoto K; Baba S; Sugimura H; Miyajima H; Furuta T
Oncotarget; 2018 Oct; 9(79):34876-34888. PubMed ID: 30405881
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
Yap WK; Chang YC; Tseng CK; Hsieh CH; Chao YK; Su PJ; Hou MM; Yang CK; Pai PC; Lin CR; Hsieh CE; Wu YY; Hung TM
Dis Esophagus; 2017 Aug; 30(8):1-10. PubMed ID: 28575243
[TBL] [Abstract][Full Text] [Related]
27. Pretreatment clinical stage predicts locoregional recurrence in patients with esophageal cancer who achieved a complete clinical response to chemoradiotherapy.
Liw PX; Wen YW; Tsai CY; Chang HK; Tseng CK; Hung TM; Chao YK
J Thorac Cardiovasc Surg; 2018 May; 155(5):2233-2242.e2. PubMed ID: 29397973
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
[TBL] [Abstract][Full Text] [Related]
29. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
30. Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers.
Takashima T; Taniyama D; Sakamoto N; Yasumoto M; Asai R; Hattori T; Honma R; Thang PQ; Ukai S; Maruyama R; Harada K; Kuraoka K; Tanabe K; Sasaki AT; Ohdan H; Morii E; Murai J; Yasui W
Br J Cancer; 2021 Jul; 125(1):65-77. PubMed ID: 33785877
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic silencing schlafen-11 sensitizes esophageal cancer to ATM inhibitor.
Zhou J; Zhang MY; Gao AA; Zhu C; He T; Herman JG; Guo MZ
World J Gastrointest Oncol; 2024 May; 16(5):2060-2073. PubMed ID: 38764821
[TBL] [Abstract][Full Text] [Related]
32. Clinical prognostic factors for locally advanced esophageal squamous carcinoma treated after definitive chemoradiotherapy.
Kim DE; Kim UJ; Choi WY; Kim MY; Kim SH; Kim MJ; Shim HJ; Hwang JE; Bae WK; Chung IJ; Nam TK; Na KJ; Cho SH
Cancer Res Treat; 2013 Dec; 45(4):276-84. PubMed ID: 24454000
[TBL] [Abstract][Full Text] [Related]
33. Type of second primary malignancy after achieving complete response by definitive chemoradiation therapy in patients with esophageal squamous cell carcinoma.
Yamaguchi T; Kato K; Nagashima K; Iwasa S; Honma Y; Takashima A; Hamaguchi T; Ito Y; Itami J; Boku N; Higuchi K
Int J Clin Oncol; 2018 Aug; 23(4):652-658. PubMed ID: 29520523
[TBL] [Abstract][Full Text] [Related]
34. NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc.
Wang Y; Cheng J; Xie D; Ding X; Hou H; Chen X; Er P; Zhang F; Zhao L; Yuan Z; Pang Q; Wang P; Qian D
Cancer Commun (Lond); 2018 Jun; 38(1):33. PubMed ID: 29871674
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of the Geriatric Nutritional Risk Index in Patients Exceeding 70 Years Old with Esophageal Squamous Cell Carcinoma.
Wang Y; Wang L; Fang M; Li J; Song T; Zhan W; Xu H
Nutr Cancer; 2020; 72(4):620-626. PubMed ID: 31390885
[TBL] [Abstract][Full Text] [Related]
36. SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer.
Winkler C; King M; Berthe J; Ferraioli D; Garuti A; Grillo F; Rodriguez-Canales J; Ferrando L; Chopin N; Ray-Coquard I; Delpuech O; Rinchai D; Bedognetti D; Ballestrero A; Leo E; Zoppoli G
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34549724
[TBL] [Abstract][Full Text] [Related]
37. Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma.
Harada K; Ida S; Baba Y; Ishimoto T; Kosumi K; Tokunaga R; Izumi D; Ohuchi M; Nakamura K; Kiyozumi Y; Imamura Y; Iwatsuki M; Iwagami S; Miyamoto Y; Sakamoto Y; Yoshida N; Watanabe M; Baba H
Dis Esophagus; 2016 Aug; 29(6):627-33. PubMed ID: 26123787
[TBL] [Abstract][Full Text] [Related]
38. Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer.
Jiang DM; Sim HW; Espin-Garcia O; Chan BA; Natori A; Lim CH; Moignard S; Chen EX; Liu G; Darling G; Swallow CJ; Brar S; Brierley J; Ringash J; Wong R; Kim J; Rogalla P; Hafezi-Bakhtiari S; Knox JJ; Jang RW; Elimova E
Oncology; 2021; 99(1):49-56. PubMed ID: 33053548
[TBL] [Abstract][Full Text] [Related]
39. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J
Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925
[TBL] [Abstract][Full Text] [Related]
40. Survival after definitive (chemo)radiotherapy in esophageal cancer patients: a population-based study in the north-East Netherlands.
Smit JK; Muijs CT; Burgerhof JG; Paardekooper G; Timmer PR; Muller K; Woutersen D; Mul VE; Beukema JC; Hospers GA; van Dijk BA; Langendijk JA; Plukker JT
Ann Surg Oncol; 2013 Jun; 20(6):1985-92. PubMed ID: 23274534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]